RadNet Inc (RDNT)

Currency in USD
75.81
-0.61(-0.80%)
Real-time Data·
RDNT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
75.5077.00
52 wk Range
50.8285.84
Key Statistics
Prev. Close
76.42
Open
77
Day's Range
75.5-77
52 wk Range
50.82-85.84
Volume
134.51K
Average Vol. (3m)
679.83K
1-Year Change
1.0512%
Book Value / Share
14.25
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RDNT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
96.57
Upside
+27.39%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period

RadNet Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 96.57
(+27.39% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
B.Riley
Buy108.00+42.22%96.00MaintainNov 11, 2026
KeyBanc
Buy95.00+25.10%92.00MaintainNov 10, 2026
Truist Securities
Buy94.00+23.78%-MaintainNov 10, 2026
Truist Securities
Buy94.00+23.78%-MaintainOct 27, 2026
Raymond James
Buy95.00+25.10%-New CoverageSep 28, 2026

RadNet Inc SWOT Analysis


Financial Ambitions
Management targets 11-13% annual revenue growth through 2028 with margin expansion of 100-150 basis points, driven by advanced imaging volume acceleration
Analyst Outlook
Price targets range from $65 to $100 with Strong Buy consensus, reflecting confidence despite screening challenges and short seller scrutiny
AI-Powered Growth
Strategic GE HealthCare partnership aims to commercialize DeepHealth's artificial intelligence portfolio domestically and internationally, diversifying revenue streams
Screening Headwinds
New JAMA guidelines recommend risk-based breast cancer screening, potentially reducing mammogram volumes by 40-45%, challenging RadNet's core business model
Read full SWOT analysis

RadNet Inc Earnings Call Summary for Q3/2026

  • RadNet Q3 2026 adjusted EPS of $0.30 beat estimates by 36%, driving shares up 2.8% to $78.10 despite revenue slightly missing at $638.3M.
  • Revenue rose 22.1% YoY to record $638.3M; adjusted EBITDA jumped 23.8% to record $105M with margin expansion to 16.5% on strong imaging volumes.
  • Company raised 2026 guidance: imaging revenue to $2.385B-$2.435B, adjusted EBITDA to $350M-$363M, and free cash flow to $120M-$130M.
  • Digital health ARR reached $112.6M with contract pipeline exceeding $300M; expects Q4 revenue above $40M and year-end ARR topping $140M, up 87% YoY.
  • ONRAD acquisition expected to close, adding $190M-$200M revenue and $60M-$65M EBITDA in year one; 161 of 439 centers now in health system partnerships.
Last Updated: 11/09/2026, 01:05 PM
Read Full Transcript

Earnings

Latest Release
Nov 08, 2026
EPS / Forecast
0.30 / 0.22
Revenue / Forecast
638.26M / 639.67M
EPS Revisions
Last 90 days

RDNT Income Statement

Compare RDNT to Peers and Sector

Metrics to compare
RDNT
Peers
Sector
Relationship
P/E Ratio
−268.3x8.2x−0.2x
PEG Ratio
3.760.110.00
Price / Book
5.4x3.6x2.6x
Price / LTM Sales
2.5x1.1x2.8x
Upside (Analyst Target)
27.3%27.6%65.0%
Fair Value Upside
Unlock3.3%9.5%Unlock

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
43.91M55.74%3.36B
Other Institutional Investors
39.32M44.26%3.01B
Public Companies & Retail Investors
0.000.00%0.00
Total
83.23M100.00%6.36B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.13.91%10,957,808837,396
RTW Investments, LP6.15%4,846,958370,405

People Also Watch

98.54
DINO
-3.56%
56.545
LQDA
-1.51%
64.53
ETON
+0.93%
67.77
PBF
-4.92%
146.96
CHRD
-1.98%

FAQ

What Is the RadNet (RDNT) Stock Price Today?

The RadNet stock price today is 75.81 USD.

What Stock Exchange Does RadNet Trade On?

RadNet is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for RadNet?

The stock symbol for RadNet is "RDNT."

What Is the RadNet Market Cap?

As of today, RadNet market cap is 5.98B USD.

What Is RadNet's Earnings Per Share (TTM)?

The RadNet EPS (TTM) is -0.29.

When Is the Next RadNet Earnings Date?

RadNet will release its next earnings report on Mar 02, 2027.

From a Technical Analysis Perspective, Is RDNT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has RadNet Stock Split?

RadNet has split 1 times.

How Many Employees Does RadNet Have?

RadNet has 9060 employees.

What is the current trading status of RadNet (RDNT)?

As of Nov 16, 2026, RadNet (RDNT) is trading at a price of 75.81 USD, with a previous close of 76.42 USD. The stock has fluctuated within a day range of 75.50 USD to 77.00 USD, while its 52-week range spans from 50.82 USD to 85.84 USD.

What Is RadNet (RDNT) Price Target According to Analysts?

The average 12-month price target for RadNet is 96.57 USD, with a high estimate of 108 USD and a low estimate of 79 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +27.39% Upside potential.

What Is the RDNT Premarket Price?

RDNT's last pre-market stock price is 77.71 USD. The pre-market share volume is 110.00, and the stock has decreased by 1.29, or 1.69%.

What Is the RDNT After Hours Price?

RDNT's last after hours stock price is 76.50 USD, the stock has decreased by 0.08, or 0.10%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.